In this GEN webinar, experts from Perceptive Imaging and Flywheel explore how imaging data access issues slow decision-making and increase risks for both biopharma and CROs.
ASPIRO is the first multi-patient, multi-center clinical trial of an autologous cell therapy for Parkinson's disease. It is evaluating safety, tolerability, and preliminary efficacy of ANPD001 in ...
After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...
Optimising RSV sample handling and laboratory workflows to support faster, more efficient clinical trial delivery.
MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...
Strategic Fit Assessment Finds Leadership Concentrated in Enterprise-Scale Clinical Performance and Resilience While Cloud ...
News-Medical.Net on MSN
TAAR1 mutation impairs brain signaling in schizophrenia
A genetic mutation passed from mother to children in families affected by schizophrenia has now been shown to completely ...
A genetic mutation passed from mother to children in families affected by schizophrenia has now been shown to completely ...
Building capacity without compromise, MaineGeneral Health’s ambient AI rollout boosts clinician adoption and reduces documentation burden effectively.
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed ...
Biolojic Design, a biotechnology company that uses computational biology and artificial intelligence (AI) to transform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback